Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension
Megan M Lowery,Nicholas S Hill,Lu Wang,Erika B Rosenzweig,Aparna Bhat,Serpil Erzurum,J Emanuel Finet,Christine L Jellis,Sunjeet Kaur,Deborah H Kwon,Rawan Nawabit,Milena Radeva,Gerald J Beck,Robert P Frantz,Paul M Hassoun,Anna R Hemnes,Evelyn M Horn,Jane A Leopold,Franz P Rischard,Reena Mehra,Pulmonary Vascular Disease Phenomics (PVDOMICS) Study Group,N Hill,L Xiao,Y-P Fu,L Postow,B Schmetter,K Stanton,X Tian,M Gray,B Wong,J Leopold,A Waxman,M DiCarli,L Lawler,B Maron,S Segrera,D Systrom,P Yu,E B Rosenzweig,S Arcasoy,D Brady,W Chung,D Payne,G Grunig,J Haythe,U Krishnan,E Horn,K Akat,A Borczuk,R Devereux,J Gordon,R Kaner,M Karas,J Min,N Narula,M Ricketts,I Sobol,R Spiera,H Singh,T Tuschl,J Weinsaft,P Hassoun,S Mathai,K Barnes,R Damico,B Enobun,L Gao,M Halushka,D Kass,T Kolb,T Lin,R Tedford,S Zimmerman,R Frantz,A Behfar,L Block,B Borlaug,L Durst,T Foley,T Hammer,B Johnson,G Johnson,G Kane,M Krowka,A McNallan,T Olson,M Redfield,K Rohwer,A Terzic,E Williamson,F Rischard,J Yuan,A Abidov,J Garcia,A Cordery,A Desai,H Erickson,L Hansen,Z Khalpey,K Knox,Y Lussier,M Simon,R Vanderpool,A Hemnes,J Newman,E Austin,E Brittain,J Cunningham,C LaRochelle,M Pugh,I Robbins,L Wheeler,G Beck,S Erzurum,M Aldred,K Asosingh,J Barnard,C Collart,S Comhair,F DiFilippo,J Drinko,R Dweik,A Flinn,M Geraci,B Hu,W Jaber,M Jacob,C Jellis,S Kalhan,K Kassimatis,J Kirsop,M Koo,D Kwon,B Larive,J Lempel,M Li,J MacKrell,B Matuska,K McCarthy,R Mehra,D Neumann,R Nawabit,M Olman,M Park,M Radeva,J Sharp,S Sherer,W Tang,J Thomas,K Wiggins,B Willard,S Rounds,R Benza,T Bull,J Cadigan,J Fang,M Gomberg-Maitland,G Page
DOI: https://doi.org/10.1016/j.jacc.2023.09.806
2023-11-21
Abstract:Background: Group 1 pulmonary arterial hypertension (PAH) is a progressive fatal condition characterized by right ventricular (RV) failure with worse outcomes in connective tissue disease (CTD). Obstructive sleep apnea and sleep-related hypoxia may contribute to RV dysfunction, though the relationship remains unclear. Objectives: The aim of this study was to prospectively evaluate the association of the apnea-hypopnea index (AHI) and sleep-related hypoxia with RV function and survival. Methods: Pulmonary Vascular Disease Phenomics (National Heart, Lung, and Blood Institute) cohort participants (patients with group 1 PAH, comparators, and healthy control participants) with sleep studies were included. Multimodal RV functional measures were examined in association with AHI and percentage of recording time with oxygen saturation <90% (T90) per 10-unit increment. Linear models, adjusted for demographics, oxygen, diffusing capacity of the lungs for carbon monoxide, pulmonary hypertension medications, assessed AHI and T90, and RV measures. Log-rank test/Cox proportional hazards models adjusted for demographics, oxygen, and positive airway pressure were constructed for transplantation-free survival analyses. Results: Analysis included 186 participants with group 1 PAH with a mean age of 52.6 ± 14.1 years; 71.5% were women, 80.8% were Caucasian, and there were 43 events (transplantation or death). AHI and T90 were associated with decreased RV ejection fraction (on magnetic resonance imaging), by 2.18% (-2.18; 95% CI: -4.00 to -0.36; P = 0.019) and 0.93% (-0.93; 95% CI: -1.47 to -0.40; P < 0.001), respectively. T90 was associated with increased RV systolic pressure (on echocardiography), by 2.52 mm Hg (2.52; 95% CI: 1.61 to 3.43; P < 0.001); increased mean pulmonary artery pressure (on right heart catheterization), by 0.27 mm Hg (0.27; 95% CI: 0.05 to 0.49; P = 0.019); and RV hypertrophy (on electrocardiography), 1.24 mm (1.24; 95% CI: 1.10 to 1.40; P < 0.001). T90, but not AHI, was associated with a 17% increased 5-year risk for transplantation or death (HR: 1.17; 95% CI: 1.07 to 1.28). In non-CTD-associated PAH, T90 was associated with a 21% increased risk for transplantation or death (HR: 1.21; 95% CI: 1.08 to 1.34). In CTD-associated PAH, T90 was associated with RV dysfunction, but not death or transplantation. Conclusions: Sleep-related hypoxia was more strongly associated than AHI with measures of RV dysfunction, death, or transplantation overall and in group 1 non-CTD-associated PAH but only with RV dysfunction in CTD-associated PAH. (Pulmonary Vascular Disease Phenomics Program [PVDOMICS]; NCT02980887).